pulmonologyadvisor4h
Treprostinil for PAH Benefits Patients Who Have Cardiovascular Comorbidities
Combination therapy with oral or inhaled treprostinil may benefit patients with pulmonary arterial hypertension and cardiovascular comorbidities.
Too Old to Operate7h
New Cutoffs Identified to Improve Timely Chronic Hypercapnia Management in COPD
Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...
healthday1d
Injurious Falls Common in Last Years of Life With COPD
Injurious falls are common among people with chronic obstructive pulmonary disease (COPD) in the two years before de ...
Too Old to Operate1d
Machine Learning-Based Speech Analysis to Predict COPD Status
The following is a summary of “Assessing the Clinical and Functional Status of COPD Patients Using Speech Analysis During and ...
Becker's Hospital Review1d
Higher fall risk in COPD patients linked to medication use: Study
A recent study conducted by researchers from Seattle-based University of Washington and Durham, N.C.-based Duke University found a strong association between the use of fall-risk increasing drugs and ...
pulmonologyadvisor2d
In COPD Treatment, Tezepelumab Not Linked to Reduced Exacerbations
Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.